Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease

Objectives: To explore serum zinc-α2-glycoprotein (ZAG) changes in patients with or without premature coronary artery disease (PCAD) and its association with several cardiovascular risk factors.Methods: A total of 3,364 patients who were undergone coronary angiography in Peking Union Medical College...

Description complète

Détails bibliographiques

Auteurs principaux:	Meijuan Liu, Huijuan Zhu, Tianshu Zhai, Hui Pan, Linjie Wang, Hongbo Yang, Kemin Yan, Yong Zeng, Fengying Gong
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2019-03-01
Collection:	Frontiers in Endocrinology
Sujets:	zinc-α2-glycoprotein (ZAG) premature coronary artery disease (PCAD) non-premature coronary artery disease (NPCAD) body mass index (BMI) diagnostic biomarker
Accès en ligne:	https://www.frontiersin.org/article/10.3389/fendo.2019.00197/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!